Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2a Pilot, Open Label, Multicenter, Study of INV-102 Ophthalmic Solution in Subjects With Diabetic Macular Edema (DME) Associated With Non-proliferative Diabetic Retinopathy (NPDR)

NCT06599684 is registered in ClinicalTrials.gov with Invirsa, Inc. as lead sponsor.

NCT NCT06599684
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06599684 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2a Pilot, Open Label, Multicenter, Study of INV-102 Ophthalmic Solution in Subjects With Diabetic Macular Edema (DME) Associated With Non-proliferative Diabetic Retinopathy (NPDR)
Lead sponsor
Invirsa, Inc.
Phase
Phase 2
Overall status
Completed
Start date
September 7, 2024
Completion date
September 30, 2025
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

center-involved diabetic macular edema, center-involved diabetic macular edema associated with non-proliferative diabetic retinopathy, diabetic retinopathy, non-center involved diabetic macular edema, non-center involved diabetic macular edema associated with non-proliferative diabetic retinopathy